Truist Financial analyst David S Macdonald reiterated a Buy rating on Molina Healthcare (MOH – Research Report) today. The company’s shares closed yesterday at $367.41.
S Macdonald covers the Healthcare sector, focusing on stocks such as Humana, Option Care Health, and Cigna. According to TipRanks, S Macdonald has an average return of 12.5% and a 64.72% success rate on recommended stocks.
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $413.13.
The company has a one-year high of $423.92 and a one-year low of $266.35. Currently, Molina Healthcare has an average volume of 401.9K.
Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Molina Healthcare (MOH) Company Description:
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Other segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico and includes direct delivery business. The Other segment includes the historical results of the MMIS and behavioral health subsidiaries. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
